Tech Transfer Central

Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition

Over 30% more royalty rate information than previous edition!
Published by Intellectual Property Research Associates, Inc.
By Russell L. Parr
Format: PDF
Publication Date: 2022
Price: $1,850
order button view cart

Royalty Rates for Pharmaceuticals & BiotechnologyRoyalty Rates for Pharmaceuticals & Biotechnology features more real-deal royalty rates, license fees, and milestone payment benchmarks than any other publication.

Nearly a decade since the last edition was published, it’s high time for the new 9th Edition of Royalty Rates for Pharmaceuticals & Biotechnology. And you know the importance of having the most up-to-date tools and data so you can optimize the pricing of your biotechnology and pharmaceutical IP. That’s why we wanted to let you know right away about the new and expanded 9th edition that includes a 30% increase in the number of reported license agreements.

The new 9th Edition includes royalty rate benchmarks on over 550 transactions – a 30% increase over the previous edition

This new 9th edition provides a wealth of deal terms and royalty rates that will provide those in the middle of technology license negotiations with real-world guidance. This one-stop source has over 550 transactions that include the technology licensed, royalty rates, upfront license fees, and milestone payments. This new edition emphasizes the reporting of royalty rates and other financial compensation associated with each license agreement.

The data covers a wide variety of technologies. Just some of the technology categories represented include: Alzheimer’s, asthma, cardiovascular, cancer, contraception, diabetes, dermatology, drug delivery, hepatitis, pain management, personal care, sleep therapy, and vaccines. You’ll find information on the parties involved in the transactions along with a description of the technology exchanged and all financial details that could be discovered.

Instantly download this hard-to-find data

Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition is provided as a printable digital download. Once you order, you get immediate access to this invaluable data. 

About the Publisher

IPRA is a consulting and publishing organization headed by founder Russell L. Parr, CFA, ASA, who has decades of consulting experience involving the valuation and pricing of patents, trademarks, copyrights and other intangible assets.

Our Guarantee of Quality and Value

We stand 100% behind the quality and value of our products. If you are dissatisfied, simply let us know and we will send you an immediate refund for your entire order -- no questions asked.

order button
view cart


Click here for a printable order form